| 20.53 Delayed Data As of Aug 23 |  0.00 / 0.00%Today’s Change | 18.14 Today|||52-Week Range 21.30 | +9.51% Year-to-Date |
| Top Analyst Reports for U.S. Bancorp, Duke Energy & Glaxo Aug 23 / Zacks.com - Paid Partner Content | Ionis Pharmaceuticals Looks to Partners to Pay the Bills Aug 14 / MotleyFool.com - Paid Partner Content |
| Pharma Stock Roundup: ABBV's Rinvoq Gets FDA Nod, BAYRY to Sell Animal Health Unit Aug 23 / Zacks.com - Paid Partner Content | Should Value Investors Consider GlaxoSmithKline (GSK) Stock? Aug 13 / Zacks.com - Paid Partner Content |
| Glaxo Submits First Regulatory Application for Daprodustat Aug 22 / Zacks.com - Paid Partner Content | AnaptysBio Prepares for a Potential Gear Shift Aug 10 / MotleyFool.com - Paid Partner Content |
| Better Buy: Eli Lilly vs. GlaxoSmithKline Aug 18 / MotleyFool.com - Paid Partner Content |
| Previous close | 20.53 |
| Today’s open | 20.73 |
| Day’s range | 20.53 - 20.75 |
| Volume | 12,991 |
| Average volume (3 months) | 3,816 |
| Market cap | $101.4B |
| Earnings growth (last year) | +143.10% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +5.72% |
| P/E ratio | 15.2 |
| Price/Sales | 2.30 |
| Price/Book | 18.02 |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $41.1B |
| Annual profit (last year) | $4.8B |
| Net profit margin | 11.75% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Executive Director Emma Walmsley |
Chief Financial Officer & Executive Director Iain James Mackay |
Corporate headquarters Brentford, Greater London |
